Incontinence Devices Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies

1 Table of Contents 3

1.1 List of Tables 10

1.2 List of Figures 18

2 Introduction 19

2.1 Incontinence Devices Overview 19

3 Products under Development 20

3.1 Incontinence Devices – Pipeline Products by Stage of Development 20

3.2 Incontinence Devices – Pipeline Products by Segment 21

3.3 Incontinence Devices – Pipeline Products by Territory 22

3.4 Incontinence Devices – Pipeline Products by Regulatory Path 23

3.5 Incontinence Devices – Pipeline Products by Estimated Approval Date 24

3.6 Incontinence Devices – Ongoing Clinical Trials 25

4 Incontinence Devices – Pipeline Products under Development by Companies 26

4.1 Incontinence Devices Companies – Pipeline Products by Stage of Development 26

4.2 Incontinence Devices – Pipeline Products by Stage of Development 31

5 Incontinence Devices Companies and Product Overview 35

5.1 3D Urologic LLC Company Overview 35

5.1.1 3D Urologic LLC Pipeline Products & Ongoing Clinical Trials Overview 35

5.2 Affluent Medical SASU Company Overview 36

5.2.1 Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview 36

5.3 All India Institute of Medical Sciences Company Overview 39

5.3.1 All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 39

5.4 Amber Therapeutics Ltd Company Overview 40

5.4.1 Amber Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

5.5 American Medical Systems Inc Company Overview 43

5.5.1 American Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 43

5.6 APRUS Bio-Medical Innovations Pvt Ltd Company Overview 44

5.6.1 APRUS Bio-Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

5.7 Aran Biomedical Company Overview 46

5.7.1 Aran Biomedical Pipeline Products & Ongoing Clinical Trials Overview 46

5.8 Atlantic Therapeutics Group Ltd Company Overview 47

5.8.1 Atlantic Therapeutics Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

5.9 AugmentRx Medical Inc. Company Overview 49

5.9.1 AugmentRx Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 49

5.10 Aurie Company Overview 50

5.10.1 Aurie Pipeline Products & Ongoing Clinical Trials Overview 50

5.11 Binding Sciences Ltd Company Overview 51

5.11.1 Binding Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

5.12 Biocrede Inc Company Overview 52

5.12.1 Biocrede Inc Pipeline Products & Ongoing Clinical Trials Overview 52

5.13 BioModics ApS Company Overview 53

5.13.1 BioModics ApS Pipeline Products & Ongoing Clinical Trials Overview 53

5.14 Bionics Institute Company Overview 54

5.14.1 Bionics Institute Pipeline Products & Ongoing Clinical Trials Overview 54

5.15 Bioring SA (Inactive) Company Overview 55

5.15.1 Bioring SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55

5.16 Boston Children’s Hospital Company Overview 56

5.16.1 Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 56

5.17 Boston Scientific Corp Company Overview 57

5.17.1 Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 57

5.18 Brighton Development LLC Company Overview 59

5.18.1 Brighton Development LLC Pipeline Products & Ongoing Clinical Trials Overview 59

5.19 Camstent Ltd Company Overview 60

5.19.1 Camstent Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

5.20 CathBuddy Inc Company Overview 63

5.20.1 CathBuddy Inc Pipeline Products & Ongoing Clinical Trials Overview 63

5.21 CELLF-Bio LLC Company Overview 64

5.21.1 CELLF-Bio LLC Pipeline Products & Ongoing Clinical Trials Overview 64

5.22 Ceragenix Pharmaceuticals, Inc. (Inactive) Company Overview 65

5.22.1 Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 65

5.23 Chain Antimicrobials Ltd Company Overview 66

5.23.1 Chain Antimicrobials Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

5.24 Collamedix Inc Company Overview 67

5.24.1 Collamedix Inc Pipeline Products & Ongoing Clinical Trials Overview 67

5.25 Coloplast A/S Company Overview 68

5.25.1 Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 68

5.26 Continale Medical Pte Ltd Company Overview 70

5.26.1 Continale Medical Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 70

5.27 Continara Limited (Inactive) Company Overview 71

5.27.1 Continara Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 71

5.28 Continental Dry-Works Company Overview 72

5.28.1 Continental Dry-Works Pipeline Products & Ongoing Clinical Trials Overview 72

5.29 Control Flo Medical LLC Company Overview 73

5.29.1 Control Flo Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 73

5.30 Dongbang Medical Co Ltd Company Overview 74

5.30.1 Dongbang Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 74

5.31 Dongguan TT Medical Inc Company Overview 75

5.31.1 Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 75

5.32 DUALIS MedTech GmbH Company Overview 76

5.32.1 DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 76

5.33 EchoScope Inc Company Overview 77

5.33.1 EchoScope Inc Pipeline Products & Ongoing Clinical Trials Overview 77

5.34 Elidah, LLC Company Overview 78

5.34.1 Elidah, LLC Pipeline Products & Ongoing Clinical Trials Overview 78

5.35 EndoStim Inc Company Overview 79

5.35.1 EndoStim Inc Pipeline Products & Ongoing Clinical Trials Overview 79

5.36 Enox Biopharma Inc (Inactive) Company Overview 80

5.36.1 Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 80

5.37 Ergoresearch Ltd Company Overview 81

5.37.1 Ergoresearch Ltd Pipeline Products & Ongoing Clinical Trials Overview 81

5.38 Essity Hygiene and Health AB Company Overview 82

5.38.1 Essity Hygiene and Health AB Pipeline Products & Ongoing Clinical Trials Overview 82

5.39 Facet Technologies LLC Company Overview 84

5.39.1 Facet Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 84

5.40 Fannin Partners LLC Company Overview 85

5.40.1 Fannin Partners LLC Pipeline Products & Ongoing Clinical Trials Overview 85

5.41 Flat Medical Inc Company Overview 86

5.41.1 Flat Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 86

5.42 FLEXIPROBE LTD. Company Overview 88

5.42.1 FLEXIPROBE LTD. Pipeline Products & Ongoing Clinical Trials Overview 88

5.43 Floelle Inc. Company Overview 89

5.43.1 Floelle Inc. Pipeline Products & Ongoing Clinical Trials Overview 89

5.44 Flume Catheter Co Ltd Company Overview 90

5.44.1 Flume Catheter Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

5.45 FocusStart LLC Company Overview 93

5.45.1 FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 93

5.46 Fuisz Pharma LLC Company Overview 94

5.46.1 Fuisz Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 94

5.47 GT Urological LLC Company Overview 95

5.47.1 GT Urological LLC Pipeline Products & Ongoing Clinical Trials Overview 95

5.48 Gweepi Medical Inc. Company Overview 96

5.48.1 Gweepi Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 96

5.49 Gynamics Ltd Company Overview 97

5.49.1 Gynamics Ltd Pipeline Products & Ongoing Clinical Trials Overview 97

5.50 Implantica CE & Production Ltd Company Overview 98

5.50.1 Implantica CE & Production Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

5.51 Ingenion Medical Ltd Company Overview 100

5.51.1 Ingenion Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 100

5.52 InterVaal Pte Ltd Company Overview 101

5.52.1 InterVaal Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

5.53 Invent Medic Sweden AB Company Overview 102

5.53.1 Invent Medic Sweden AB Pipeline Products & Ongoing Clinical Trials Overview 102

5.54 Jabil Inc Company Overview 103

5.54.1 Jabil Inc Pipeline Products & Ongoing Clinical Trials Overview 103

5.55 John D. Dingell VA Medical Center Company Overview 104

5.55.1 John D. Dingell VA Medical Center Pipeline Products & Ongoing Clinical Trials Overview 104

5.56 Laborie Medical Technologies Inc Company Overview 105

5.56.1 Laborie Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 105

5.57 Leading Age Supplies LLC Company Overview 107

5.57.1 Leading Age Supplies LLC Pipeline Products & Ongoing Clinical Trials Overview 107

5.58 Levee Medical Inc Company Overview 108

5.58.1 Levee Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 108

5.59 Lilium Otsuka Co., Ltd. Company Overview 111

5.59.1 Lilium Otsuka Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 111

5.60 MagCath ApS Company Overview 112

5.60.1 MagCath ApS Pipeline Products & Ongoing Clinical Trials Overview 112

5.61 Medici Medical Srl Company Overview 113

5.61.1 Medici Medical Srl Pipeline Products & Ongoing Clinical Trials Overview 113

5.62 Medi-Globe GmbH Company Overview 114

5.62.1 Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 114

5.63 Medlarks Pvt Ltd Company Overview 115

5.63.1 Medlarks Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 115

5.64 Montana State University Company Overview 116

5.64.1 Montana State University Pipeline Products & Ongoing Clinical Trials Overview 116

5.65 MyoPowers Medical Technologies France SAS Company Overview 117

5.65.1 MyoPowers Medical Technologies France SAS Pipeline Products & Ongoing Clinical Trials Overview 117

5.66 N8 Medical LLC Company Overview 118

5.66.1 N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 118

5.67 Novuqare BV Company Overview 119

5.67.1 Novuqare BV Pipeline Products & Ongoing Clinical Trials Overview 119

5.68 Olympus Endo Technology America Inc Company Overview 120

5.68.1 Olympus Endo Technology America Inc Pipeline Products & Ongoing Clinical Trials Overview 120

5.69 OTU Medical Inc Company Overview 121

5.69.1 OTU Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 121

5.70 Pelvital USA Inc Company Overview 123

5.70.1 Pelvital USA Inc Pipeline Products & Ongoing Clinical Trials Overview 123

5.71 Pennsylvania State University Company Overview 124

5.71.1 Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 124

5.72 PetVivo Holdings Inc Company Overview 125

5.72.1 PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 125

5.73 Plus Therapeutics Inc Company Overview 126

5.73.1 Plus Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 126

5.74 PolyNovo Biomaterials Pty Ltd Company Overview 127

5.74.1 PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 127

5.75 Polytechnic University of Catalonia Company Overview 128

5.75.1 Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 128

5.76 Polytechnique Montreal Company Overview 130

5.76.1 Polytechnique Montreal Pipeline Products & Ongoing Clinical Trials Overview 130

5.77 Precision Medical Devices Inc Company Overview 131

5.77.1 Precision Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 131

5.78 Prosurg Inc Company Overview 132

5.78.1 Prosurg Inc Pipeline Products & Ongoing Clinical Trials Overview 132

5.79 Provenmed Company Overview 133

5.79.1 Provenmed Pipeline Products & Ongoing Clinical Trials Overview 133

5.80 Pyriscence LLC Company Overview 134

5.80.1 Pyriscence LLC Pipeline Products & Ongoing Clinical Trials Overview 134

5.81 Quick-Med Technologies Inc Company Overview 135

5.81.1 Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 135

5.82 RegenMedTX LLC Company Overview 136

5.82.1 RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview 136

5.83 Relief Srl Company Overview 137

5.83.1 Relief Srl Pipeline Products & Ongoing Clinical Trials Overview 137

5.84 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Company Overview 140

5.84.1 Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 140

5.85 Riocath Global AS Company Overview 141

5.85.1 Riocath Global AS Pipeline Products & Ongoing Clinical Trials Overview 141

5.86 Salusion B.V. Company Overview 146

5.86.1 Salusion B.V. Pipeline Products & Ongoing Clinical Trials Overview 146

5.87 Sharklet Technologies Inc Company Overview 147

5.87.1 Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 147

5.88 Stanford University Company Overview 148

5.88.1 Stanford University Pipeline Products & Ongoing Clinical Trials Overview 148

5.89 The Feinstein Institute for Medical Research Company Overview 149

5.89.1 The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 149

5.90 The University of Nottingham Company Overview 150

5.90.1 The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 150

5.91 Tractivus SL Company Overview 151

5.91.1 Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview 151

5.92 University of Amsterdam Company Overview 152

5.92.1 University of Amsterdam Pipeline Products & Ongoing Clinical Trials Overview 152

5.93 University of California San Diego Company Overview 153

5.93.1 University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 153

5.94 University of Michigan Pediatric Device Consortium Company Overview 154

5.94.1 University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 154

5.95 University of North Carolina Company Overview 155

5.95.1 University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview 155

5.96 University of Saskatchewan Company Overview 156

5.96.1 University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview 156

5.97 University of Sheffield Company Overview 157

5.97.1 University of Sheffield Pipeline Products & Ongoing Clinical Trials Overview 157

5.98 University of South Florida Company Overview 158

5.98.1 University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 158

5.99 University of Texas Health Science Center at San Antonio Company Overview 160

5.99.1 University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 160

5.100 University of Turin Company Overview 161

5.100.1 University of Turin Pipeline Products & Ongoing Clinical Trials Overview 161

5.101 University of Utah Company Overview 162

5.101.1 University of Utah Pipeline Products & Ongoing Clinical Trials Overview 162

5.102 Urinary BioSolutions LLC (Inactive) Company Overview 164

5.102.1 Urinary BioSolutions LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 164

5.103 UroDeflect Company Overview 165

5.103.1 UroDeflect Pipeline Products & Ongoing Clinical Trials Overview 165

5.104 UroDev Medical Company Overview 166

5.104.1 UroDev Medical Pipeline Products & Ongoing Clinical Trials Overview 166

5.105 Uromedica Inc Company Overview 167

5.105.1 Uromedica Inc Pipeline Products & Ongoing Clinical Trials Overview 167

5.106 UroMems SAS Company Overview 170

5.106.1 UroMems SAS Pipeline Products & Ongoing Clinical Trials Overview 170

5.107 Urova Medical Inc. Company Overview 173

5.107.1 Urova Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 173

5.108 Urwi Medical Innovations Pvt Ltd Company Overview 174

5.108.1 Urwi Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 174

5.109 Vesiflo, Inc. Company Overview 175

5.109.1 Vesiflo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 175

5.110 Viveve Medical Inc Company Overview 176

5.110.1 Viveve Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 176

5.111 Vysera Biomedical Ltd Company Overview 177

5.111.1 Vysera Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 177

5.112 Washington University in St Louis Company Overview 178

5.112.1 Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 178

5.113 Watkins Conti Products Inc Company Overview 179

5.113.1 Watkins Conti Products Inc Pipeline Products & Ongoing Clinical Trials Overview 179

5.114 Xennovate Medical LLC Company Overview 180

5.114.1 Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 180

6 Incontinence Devices- Recent Developments 181

6.1 May 07, 2024: Unicharm Announces Consolidated Financial Results for the First Quarter of the Fiscal Year Ending December 31, 2024 181

6.2 May 07, 2024: AdaptHealth Announces First Quarter 2024 Results 181

6.3 May 07, 2024: Unicharm Corp Announces First Quarter of Fiscal Year Ending December 31, 2024 182

6.4 Apr 30, 2024: Coloplast Receives 510(K) Clearance For Folysil Silicone Catheter 182

6.5 Apr 24, 2024: Medtronic Names Yarmela Pavlovic as Chief Regulatory Officer 182

6.6 Apr 17, 2024: SeaStar Medical Reports 2023 Financial Results and Provides a Business Update 182

6.7 Apr 16, 2024: Resilia Pharmaceuticals Receives Additional FDA 510(k) Clearance for Uresta Pessary 184

6.8 Apr 11, 2024: Bactiguard Holding Announces Annual and Sustainability Report 2023 184

6.9 Apr 02, 2024: Medline Expands Catheter Portfolio with QiVi MEC Male External Urine Management Device 185

6.10 Mar 19, 2024: Gynesonics Announces Key Executive Appointments to Further Accelerate and Expand Adoption of the Sonata Treatment 185

6.11 Mar 12, 2024: Affluent Medical announces successful first-in-human implantation of its artificial sphincter Artus for the treatmentof stress urinary incontinence 186

6.12 Mar 12, 2024: Medtronic To Present At Barclays Global Healthcare Conference 187

6.13 Mar 08, 2024: Axena Health study shows incontinence is a major burden for women in Kenya and Nigeria 187

6.14 Mar 05, 2024: Axena secures new HCPCS code for Leva Pelvic Health System 188

6.15 Mar 04, 2024: Shenzhen Konmed Technology Receives 510(K) Clearance For Rectal Electrode Probe 189

6.16 Mar 01, 2024: Shenzhen Konmed Technology Receives 510(K) Clearance For Vaginal Electrode Probe 189

6.17 Feb 28, 2024: Covalon to Hold Annual Meeting of Shareholders on Wednesday, March 6, 2024 189

6.18 Feb 28, 2024: Shandong Weigao Group Medical Polymer Announces Preliminary Results for the Year Ended 31 December 2023 190

6.19 Feb 28, 2024: Boston Scientific Raises $2.2B to Support Purchase of California Medical Device Company 190

6.20 Feb 27, 2024: Amber Therapeutics Announces Positive Preliminary Results from its First-in-Human Investigation of Amber-UI, its new Adaptive Implanted Pudendal Neuromodulation System for Urinary Incontinence 190

6.21 Feb 23, 2024: Medical Tech Leader, Boston Scientific (BSX), Announces Notes Offering 191

6.22 Feb 22, 2024: Zynex Sets Fourth Quarter and Full Year 2023 Earnings Call 191

6.23 Feb 22, 2024: Sanofi’s Board of Directors Proposes the Appointment of Clotilde Delbos, Anne-Francoise Nesmes and John Sundy as Independent Directors 192

6.24 Feb 19, 2024: Boston Scientific Appoints Madan Krishnan to Lead India Subcontinent 193

6.25 Feb 16, 2024: Jim Robo, Former Chairman and CEO of NextEra Energy, to Join Mayo Clinic Board of Trustees 193

6.26 Feb 15, 2024: UroMems Announces Results of First-Ever Smart Artificial Urinary Sphincter Implant in Female Patient to Treat Stress Urinary Incontinence 193

6.27 Feb 09, 2024: Coloplast Announces Interim Financial Report, Q1 2023/24 194

6.28 Feb 08, 2024: ConvaTec Group Receives 510(K) Clearance For GentleCath Air for Women 195

6.29 Feb 08, 2024: Silq Technologies Received Additional 510(K) Clearance For 2-Way 100% Silicone ClearTract Catheter 196

6.30 Feb 08, 2024: Teleflex Announces Fourth Quarter 2023 Earnings Conference Call Information 196

6.31 Feb 07, 2024: Bactiguard Holding Appoints Christine Lind as New CEO 196

6.32 Feb 01, 2024: Sanofi Announces Quarterly Earnings Report and Stock Performance Analysis 197

6.33 Feb 01, 2024: Francois-Xavier Roger Appointed Chief Financial Officer, Member of Sanofi Executive Committee 197

6.34 Feb 01, 2024: Bactiguard Holding Announces Invitation to Presentation of Year-end Report for 2023 198

6.35 Jan 31, 2024: Boston Scientific Announces Results for Fourth Quarter and Full Year 2023 198

6.36 Jan 26, 2024: Covalon Announces Management Changes 200

6.37 Jan 23, 2024: Axena Health Commends New Study Showing the Leva System’s Long-term Treatment Efficacy for Female Urinary Incontinence 200

6.38 Jan 22, 2024: Axena Health Studies Barriers to First-Line Treatment for Urinary Incontinence 201

6.39 Jan 09, 2024: Axena Health Welcomes 4 Distributors for the Leva Pelvic Health System 202

6.40 Jan 09, 2024: Brian Foard Appointed Head of Specialty Care Global Business Unit, Member of Sanofi Executive Committee 203

6.41 Jan 08, 2024: Pelvital USA Receives Additional 510(K) Clearance For Flyte System 204

6.42 Jan 05, 2024: Boston Scientific Announces Conference Call Discussing Fourth Quarter 2023 Results 204

6.43 Jan 04, 2024: Covalon Technologies Announces the Appointment of Experienced MedTech Executive Mr. Brent Ashton as New CEO 204

6.44 Dec 13, 2023: Uromems Reaches Significant Milestone: Successful Results in Clinical Feasibility Study of Uroactive Smart Implant for Stress Urinary Incontinence Treatment 205

6.45 Nov 14, 2023: SeaStar Medical Reports Third Quarter 2023 Financial Results and Provides a Business Update 206

6.46 Nov 13, 2023: INVO Reports Record Third Quarter 2023 Financial Results 209

6.47 Nov 09, 2023: Coloplast Reports Annual Report 2022/23 210

6.48 Nov 07, 2023: ProstaLund Announces Interim Report 211

6.49 Nov 07, 2023: AdaptHealth Announces Third Quarter 2023 Results 212

6.50 Nov 05, 2023: Teleflex Reports Third Quarter Financial Results, Full Year 2023 Outlook 213

6.51 Nov 02, 2023: Dentsply Sirona Announces Appointment of Mr. Brian Gladden as New Board Member 213

6.52 Oct 27, 2023: Bactiguard Holding Announces Interim Report Q3 2023 213

6.53 Oct 26, 2023: Boston Scientific Announces Results for Third Quarter 2023 215

6.54 Oct 12, 2023: The Exact Onset of the Effect of Botox in Real Time With Use of Our Diary Pod 217

6.55 Oct 10, 2023: HR Pharmaceuticals, Significantly Expands the Trucath Portfolio With Two New Offerings of Ready-To-Use Intermittent Catheters Delivering Optimal Protection, Comfort, and Convenience 218

6.56 Oct 06, 2023: PFD Week Abstracts Show Leva’s Long-Term Treatment Value for Female Urinary Incontinence Plus New Data for Other Pelvic Floor Disorders 218

6.57 Oct 04, 2023: Medtronic Names Paolo Di Vincenzo President of the Neuromodulation Business 219

6.58 Sep 29, 2023: Barry Slowey Named Vice President and Chief Sustainability Officer 220

6.59 Sep 18, 2023: Shandong Weigao Group Medical Polymer Co. Notice of the Third Extraordinary General Meeting 220

6.60 Sep 15, 2023: Amber Beauchamp Named Vice President of Global Human Resources 221

6.61 Sep 13, 2023: UroMems completes device implants for stress urinary incontinence trial 221

6.62 Sep 08, 2023: Coloplast Receives 510(k) Clearance for Luja 222

6.63 Aug 31, 2023: Sanofi Appoints a Venture Investor to R&D Head as Executive Team Expands 222

6.64 Aug 30, 2023: CooperCompanies Announces Third Quarter 2023 Results 222

6.65 Aug 29, 2023: Coloplast Launches Offering to Raise Around Dkk 9 Billion Through Issue of New B Shares in a Directed Issue and Private Placement 224

6.66 Aug 26, 2023: Medtronic Q2 2024 Earnings Estimates Increased by William Blair 225

6.67 Aug 18, 2023: Coloplast Receives 510(k) Clearance for Self-Cath Closed System 225

6.68 Aug 17, 2023: Mayo Clinic Reports Strong Finances for 2023 So Far with Q2 Revenue of $4.47 billion 226

6.69 Aug 15, 2023: Convatec Group Appoints Robyn Butler-Mason as Company Secretary 226

6.70 Aug 12, 2023: Centenial Surgical Suture Re-appoints Ms. Anuradha Kashikar as Executive Director 226

6.71 Aug 11, 2023: Kristin Peck, CEO of Zoetis, to join Mayo Clinic Board of Trustees 226

6.72 Aug 10, 2023: Teleflex Medical Receives 510(k) Clearance for Rusch SoftSimplastic Foley Catheter 227

6.73 Aug 08, 2023: Medtronic to Announce Financial Results for its First Quarter of Fiscal Year 2024 227

6.74 Aug 04, 2023: Unicharm Announces Second Quarter of the Fiscal Year Ending December 31, 2023 227

6.75 Aug 03, 2023: Teleflex Reports Second Quarter Financial Results and Full Year 2023 Outlook 227

6.76 Aug 02, 2023: ConvaTec Group Announces Interim Results for the six months ended 30 June 2023 231

6.77 Jul 28, 2023: Ontex Reports H1 2023 results 231

6.78 Jul 21, 2023: UroMems announces first implantation of UroActive in a female patient 235

6.79 Jul 19, 2023: Boston Scientific lays off 52 workers as it closes another Silicon Valley facility 236

6.80 Jul 12, 2023: Flume Catheter Receives Additional 510(k) Clearance for Flume Catheter 236

6.81 Jun 28, 2023: Medline Announces Leadership Transition Naming New CEO and President & COO 236

6.82 Jun 27, 2023: AdaptHealth Appoints Crispin Teufel as New Chief Executive Officer 237

6.83 Jun 26, 2023: Covalon Announces Participation in APIC Annual Conference & Exposition on June 26 – 28, 2023 in Orlando, Florida 237

6.84 Jun 22, 2023: Axena Health Celebrates “Best Overall” Abstract Showing the Leva System’s Long-Term Efficacy for Female Urinary Incontinence 238

6.85 Jun 20, 2023: Axena Health Delivers At-Home Treatment for Chronic Fecal Incontinence in Women 240

6.86 Jun 13, 2023: Well Lead Medical Receives Additional 510(k) Clearance for PVC Hydrophilic Urethral Catheter 241

6.87 Jun 12, 2023: Minze Uroflowmeter : Streamlining Urology Practices with Minze Uroflowmetry Systems: Hospiflow and Homeflow 241

6.88 Jun 06, 2023: UroMems Announces Results of First Patient in Smart Implant Study to Treat Stress Urinary Incontinence 242

6.89 May 29, 2023: Weigao Group Medical Polymer announces poll results of annual general meeting held on 29 May 2023 243

6.90 May 27, 2023: Centenial Surgical Suture Announces Standalone Audited Financial Results for the Quarter and Year Ended March 31, 2023 243

6.91 May 26, 2023: Observe Medical announces minutes from annual general meeting 243

7 Appendix 244

7.1 Methodology 244

7.2 About GlobalData 247

7.3 Contact Us 247

7.4 Disclaimer 247

Incontinence Devices – Pipeline Products by Stage of Development 20

Incontinence Devices – Pipeline Products by Segment 21

Incontinence Devices – Pipeline Products by Territory 22

Incontinence Devices – Pipeline Products by Regulatory Path 23

Incontinence Devices – Pipeline Products by Estimated Approval Date 24

Incontinence Devices – Ongoing Clinical Trials 25

Incontinence Devices Companies – Pipeline Products by Stage of Development 26

Incontinence Devices – Pipeline Products by Stage of Development 31

3D Urologic LLC Pipeline Products & Ongoing Clinical Trials Overview 35

3D Urologic Device – Product Status 35

3D Urologic Device – Product Description 35

Affluent Medical SASU Pipeline Products & Ongoing Clinical Trials Overview 36

Artus – Product Status 36

Artus – Product Description 36

Affluent Medical SASU – Ongoing Clinical Trials Overview 37

Artus – Safety and Clinical Performance Study of the ARTUS Artificial Urinary Sphincter (AUS) for the Treatment of Stress Urinary Incontinence (SUI) Due to Intrinsic Sphincter Deficiency 38

All India Institute of Medical Sciences Pipeline Products & Ongoing Clinical Trials Overview 39

Super Hydrophobic Catheter – Product Status 39

Super Hydrophobic Catheter – Product Description 39

Amber Therapeutics Ltd Pipeline Products & Ongoing Clinical Trials Overview 40

Amber-UI Bioelectronic System – Product Status 40

Amber-UI Bioelectronic System – Product Description 40

Amber Therapeutics Ltd – Ongoing Clinical Trials Overview 41

Amber-UI Bioelectronic System – Exploratory Safety and Electrophysiological Study of Closed-loop Pudendal Neuromodulation Using an Implantable (Picostim-DyNeuMo) Device in Women with Urinary Incontinence 42

American Medical Systems Inc Pipeline Products & Ongoing Clinical Trials Overview 43

TOPAS Sling System – Product Status 43

TOPAS Sling System – Product Description 43

APRUS Bio-Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 44

Incontinence Device – Adults – Product Status 44

Incontinence Device – Adults – Product Description 44

Incontinence Device – Children – Product Status 45

Incontinence Device – Children – Product Description 45

Aran Biomedical Pipeline Products & Ongoing Clinical Trials Overview 46

Biomaterial-Based Incontinence Device – Product Status 46

Biomaterial-Based Incontinence Device – Product Description 46

Atlantic Therapeutics Group Ltd Pipeline Products & Ongoing Clinical Trials Overview 47

Next Generation INNOVO – Product Status 47

Next Generation INNOVO – Product Description 47

Stress Urinary Incontinence Device – Men – Product Status 48

Stress Urinary Incontinence Device – Men – Product Description 48

AugmentRx Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 49

SOLVE – Product Status 49

SOLVE – Product Description 49

Aurie Pipeline Products & Ongoing Clinical Trials Overview 50

Reusable Intermittent Catheter System – Product Status 50

Reusable Intermittent Catheter System – Product Description 50

Binding Sciences Ltd Pipeline Products & Ongoing Clinical Trials Overview 51

RS – WP06 – Product Status 51

RS – WP06 – Product Description 51

Biocrede Inc Pipeline Products & Ongoing Clinical Trials Overview 52

Urinary Catheter – Product Status 52

Urinary Catheter – Product Description 52

BioModics ApS Pipeline Products & Ongoing Clinical Trials Overview 53

Indwelling Urinary Catheter – Product Status 53

Indwelling Urinary Catheter – Product Description 53

Bionics Institute Pipeline Products & Ongoing Clinical Trials Overview 54

Bladder Function Monitoring Device – Product Status 54

Bladder Function Monitoring Device – Product Description 54

Bioring SA (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 55

Biowing – Product Status 55

Biowing – Product Description 55

Boston Children’s Hospital Pipeline Products & Ongoing Clinical Trials Overview 56

Artificial Urinary Sphincter – Product Status 56

Artificial Urinary Sphincter – Product Description 56

Boston Scientific Corp Pipeline Products & Ongoing Clinical Trials Overview 57

Pathfinder RP – Product Status 57

Pathfinder RP – Product Description 57

Pathfinder TOT – Product Status 58

Pathfinder TOT – Product Description 58

Brighton Development LLC Pipeline Products & Ongoing Clinical Trials Overview 59

Antimicrobial Catheter – Catheter Associated Urinary Tract Infection – Product Status 59

Antimicrobial Catheter – Catheter Associated Urinary Tract Infection – Product Description 59

Camstent Ltd Pipeline Products & Ongoing Clinical Trials Overview 60

Camstent Coated Foley Catheter – Product Status 60

Camstent Coated Foley Catheter – Product Description 60

Camstent Ltd – Ongoing Clinical Trials Overview 61

Camstent Coated Foley Catheter – A Prospective Multicentre Randomized Study to Assess the Impact of a Catheter Coating on Clinical Bacteriuria 62

CathBuddy Inc Pipeline Products & Ongoing Clinical Trials Overview 63

Urinary Catheterization System – Product Status 63

Urinary Catheterization System – Product Description 63

CELLF-Bio LLC Pipeline Products & Ongoing Clinical Trials Overview 64

Urinary Incontinence Device – Product Status 64

Urinary Incontinence Device – Product Description 64

Ceragenix Pharmaceuticals, Inc. (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 65

Cerashield Coated Silicone Urinary Catheter – Product Status 65

Cerashield Coated Silicone Urinary Catheter – Product Description 65

Chain Antimicrobials Ltd Pipeline Products & Ongoing Clinical Trials Overview 66

Peptide-Coated Catheter – Product Status 66

Peptide-Coated Catheter – Product Description 66

Collamedix Inc Pipeline Products & Ongoing Clinical Trials Overview 67

CollaSling – Product Status 67

CollaSling – Product Description 67

Coloplast A/S Pipeline Products & Ongoing Clinical Trials Overview 68

Luja – Product Status 68

Luja – Product Description 69

Single-Use Compact Female Intermittent Catheter – Product Status 69

Single-Use Compact Female Intermittent Catheter – Product Description 69

Continale Medical Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 70

AeraVas – Product Status 70

AeraVas – Product Description 70

Continara Limited (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 71

UTROL Bionic Sphincter – Product Status 71

UTROL Bionic Sphincter – Product Description 71

Continental Dry-Works Pipeline Products & Ongoing Clinical Trials Overview 72

The Pocket – Product Status 72

The Pocket – Product Description 72

Control Flo Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 73

ResQ Urological Catheter System – Product Status 73

ResQ Urological Catheter System – Product Description 73

Dongbang Medical Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 74

Incontinence Sling Kit – Product Status 74

Incontinence Sling Kit – Product Description 74

Dongguan TT Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 75

Drug-coated Catheter – Product Status 75

Drug-coated Catheter – Product Description 75

DUALIS MedTech GmbH Pipeline Products & Ongoing Clinical Trials Overview 76

Implantable Wireless Sphincter System – Product Status 76

Implantable Wireless Sphincter System – Product Description 76

EchoScope Inc Pipeline Products & Ongoing Clinical Trials Overview 77

EchoScope Device – Product Status 77

EchoScope Device – Product Description 77

Elidah, LLC Pipeline Products & Ongoing Clinical Trials Overview 78

Edytone – Product Status 78

Edytone – Product Description 78

EndoStim Inc Pipeline Products & Ongoing Clinical Trials Overview 79

Implantable Device – Urinary Incontinence – Product Status 79

Implantable Device – Urinary Incontinence – Product Description 79

Enox Biopharma Inc (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 80

Self-Sterilizing Urinary Catheter – Product Status 80

Self-Sterilizing Urinary Catheter – Product Description 80

Ergoresearch Ltd Pipeline Products & Ongoing Clinical Trials Overview 81

Urinary Disorders Implant – Product Status 81

Urinary Disorders Implant – Product Description 81

Essity Hygiene and Health AB Pipeline Products & Ongoing Clinical Trials Overview 82

SN2 – Product Status 82

SN2 – Product Description 82

SP3 – Product Status 82

SP3 – Product Description 83

Facet Technologies LLC Pipeline Products & Ongoing Clinical Trials Overview 84

Periurethral Device – Product Status 84

Periurethral Device – Product Description 84

Fannin Partners LLC Pipeline Products & Ongoing Clinical Trials Overview 85

Securine Device – Product Status 85

Securine Device – Product Description 85

Flat Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 86

UroAid – F – Product Status 86

UroAid – F – Product Description 86

UroAid – IV – Product Status 87

UroAid – IV – Product Description 87

FLEXIPROBE LTD. Pipeline Products & Ongoing Clinical Trials Overview 88

Flexiprobe Device – Product Status 88

Flexiprobe Device – Product Description 88

Floelle Inc. Pipeline Products & Ongoing Clinical Trials Overview 89

Floelle Device – Product Status 89

Floelle Device – Product Description 89

Flume Catheter Co Ltd Pipeline Products & Ongoing Clinical Trials Overview 90

Flume Catheter – Product Status 90

Flume Catheter – Product Description 90

Flume Catheter Co Ltd – Ongoing Clinical Trials Overview 91

Flume Catheter – FLUME Catheter Comfort Study 92

FocusStart LLC Pipeline Products & Ongoing Clinical Trials Overview 93

Anti-biofilm Urological Catheter – Product Status 93

Anti-biofilm Urological Catheter – Product Description 93

Fuisz Pharma LLC Pipeline Products & Ongoing Clinical Trials Overview 94

Fuisz Device – Product Status 94

Fuisz Device – Product Description 94

GT Urological LLC Pipeline Products & Ongoing Clinical Trials Overview 95

Implantable Incontinence Device – Product Status 95

Implantable Incontinence Device – Product Description 95

Gweepi Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 96

SmartBrief System – Product Status 96

SmartBrief System – Product Description 96

Gynamics Ltd Pipeline Products & Ongoing Clinical Trials Overview 97

Nolix – Product Status 97

Nolix – Product Description 97

Implantica CE & Production Ltd Pipeline Products & Ongoing Clinical Trials Overview 98

UriControl – Product Status 98

UriControl – Product Description 98

UriRestore – Product Status 99

UriRestore – Product Description 99

Ingenion Medical Ltd Pipeline Products & Ongoing Clinical Trials Overview 100

FemActive Catheter – Product Status 100

FemActive Catheter – Product Description 100

InterVaal Pte Ltd Pipeline Products & Ongoing Clinical Trials Overview 101

InterVaal Catheter – Product Status 101

InterVaal Catheter – Product Description 101

Invent Medic Sweden AB Pipeline Products & Ongoing Clinical Trials Overview 102

Efemia Bladder Support – Product Status 102

Efemia Bladder Support – Product Description 102

Jabil Inc Pipeline Products & Ongoing Clinical Trials Overview 103

Shakoori Relief Valve – Product Status 103

Shakoori Relief Valve – Product Description 103

John D. Dingell VA Medical Center Pipeline Products & Ongoing Clinical Trials Overview 104

Smart Artificial Urinary Sphincter Device – Product Status 104

Smart Artificial Urinary Sphincter Device – Product Description 104

Laborie Medical Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 105

G2 Urostym – Product Status 105

G2 Urostym – Product Description 105

T-DOC 5Fr Air-Charged Catheter – Product Status 106

T-DOC 5Fr Air-Charged Catheter – Product Description 106

Leading Age Supplies LLC Pipeline Products & Ongoing Clinical Trials Overview 107

Urinary Catheter – Product Status 107

Urinary Catheter – Product Description 107

Levee Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 108

Voro Urologic Scaffold – Product Status 108

Voro Urologic Scaffold – Product Description 108

Levee Medical Inc – Ongoing Clinical Trials Overview 109

Voro Urologic Scaffold – Feasibility Study of A Voro Urologic Scaffold for the Prophylactic Treatment of Post-Prostatectomy Stress Urinary Incontinence 110

Lilium Otsuka Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview 111

Next Gen Yuririn USH-052 Scanner – Product Status 111

Next Gen Yuririn USH-052 Scanner – Product Description 111

MagCath ApS Pipeline Products & Ongoing Clinical Trials Overview 112

Obtinu Device – Product Status 112

Obtinu Device – Product Description 112

Medici Medical Srl Pipeline Products & Ongoing Clinical Trials Overview 113

Time-Delayed Valve System – Product Status 113

Time-Delayed Valve System – Product Description 113

Medi-Globe GmbH Pipeline Products & Ongoing Clinical Trials Overview 114

Incontinence Prosthesis – Product Status 114

Incontinence Prosthesis – Product Description 114

Medlarks Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 115

UroVib – Product Status 115

UroVib – Product Description 115

Montana State University Pipeline Products & Ongoing Clinical Trials Overview 116

Safety Adaptor For Foley Catheter – Product Status 116

Safety Adaptor For Foley Catheter – Product Description 116

MyoPowers Medical Technologies France SAS Pipeline Products & Ongoing Clinical Trials Overview 117

ARTUS MONO – Product Status 117

ARTUS MONO – Product Description 117

N8 Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 118

CeraShield Urinary Catheter – Product Status 118

CeraShield Urinary Catheter – Product Description 118

Novuqare BV Pipeline Products & Ongoing Clinical Trials Overview 119

MAXAM Pelvic Floor Device – Product Status 119

MAXAM Pelvic Floor Device – Product Description 119

Olympus Endo Technology America Inc Pipeline Products & Ongoing Clinical Trials Overview 120

Uro-Ease – Product Status 120

Uro-Ease – Product Description 120

OTU Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 121

NextGen Purewick – Product Status 121

NextGen Purewick – Product Description 121

Portable Purewick – Product Status 122

Portable Purewick – Product Description 122

Purewick No Touch – Product Status 122

Purewick No Touch – Product Description 122

Pelvital USA Inc Pipeline Products & Ongoing Clinical Trials Overview 123

Next Generation Flyte System – Product Status 123

Next Generation Flyte System – Product Description 123

Pennsylvania State University Pipeline Products & Ongoing Clinical Trials Overview 124

Smart Wrap – Product Status 124

Smart Wrap – Product Description 124

PetVivo Holdings Inc Pipeline Products & Ongoing Clinical Trials Overview 125

Female Urinary Incontinence Device – Product Status 125

Female Urinary Incontinence Device – Product Description 125

Plus Therapeutics Inc Pipeline Products & Ongoing Clinical Trials Overview 126

ECCI-50 – Male Stress Urinary Incontinence – Product Status 126

ECCI-50 – Male Stress Urinary Incontinence – Product Description 126

PolyNovo Biomaterials Pty Ltd Pipeline Products & Ongoing Clinical Trials Overview 127

Novosorb – Bladder Sling – Product Status 127

Novosorb – Bladder Sling – Product Description 127

Polytechnic University of Catalonia Pipeline Products & Ongoing Clinical Trials Overview 128

Biofeedback System – Urinary Incontinence – Product Status 128

Biofeedback System – Urinary Incontinence – Product Description 129

Polytechnique Montreal Pipeline Products & Ongoing Clinical Trials Overview 130

Bladder Implant – Product Status 130

Bladder Implant – Product Description 130

Precision Medical Devices Inc Pipeline Products & Ongoing Clinical Trials Overview 131

Politano-Sayet-Sutherland Flow Control Device – Product Status 131

Politano-Sayet-Sutherland Flow Control Device – Product Description 131

Prosurg Inc Pipeline Products & Ongoing Clinical Trials Overview 132

ConstrictX – Product Status 132

ConstrictX – Product Description 132

Provenmed Pipeline Products & Ongoing Clinical Trials Overview 133

ActivGo Kit – Product Status 133

ActivGo Kit – Product Description 133

Pyriscence LLC Pipeline Products & Ongoing Clinical Trials Overview 134

Anti-Microbial Catheter – Product Status 134

Anti-Microbial Catheter – Product Description 134

Quick-Med Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 135

Incontinence Device – Product Status 135

Incontinence Device – Product Description 135

RegenMedTX LLC Pipeline Products & Ongoing Clinical Trials Overview 136

Neo Bladder Augment – Urge Incontinence – Product Status 136

Neo Bladder Augment – Urge Incontinence – Product Description 136

Relief Srl Pipeline Products & Ongoing Clinical Trials Overview 137

Magnetic Endourethral Sphincter – Product Status 137

Magnetic Endourethral Sphincter – Product Description 137

Relief Srl – Ongoing Clinical Trials Overview 138

Magnetic Endourethral Sphincter – Multicentric Pilot Study for the Application of a Magnetic Endourethral Sphincter for the Treatment of Secondary Stress Urinary Incontinence Damage to the Urethral Sphincter 139

Resultados y Calidad del Sistema Sanitario Publico de Andalucia Pipeline Products & Ongoing Clinical Trials Overview 140

Permanent Urinary Catheter Shutter – Product Status 140

Permanent Urinary Catheter Shutter – Product Description 140

Riocath Global AS Pipeline Products & Ongoing Clinical Trials Overview 141

Epicystostomy Catheter – Product Status 141

Epicystostomy Catheter – Product Description 141

Female Urinary Catheter Permanent – Product Status 142

Female Urinary Catheter Permanent – Product Description 142

Female Urinary Catheter Simple – Product Status 142

Female Urinary Catheter Simple – Product Description 143

Female Urinary Catheter With Insertion Tool – Product Status 143

Female Urinary Catheter With Insertion Tool – Product Description 143

Male Urinary Catheter Permanent – Product Status 144

Male Urinary Catheter Permanent – Product Description 144

Male Urinary Catheter With Insertion Tool – Product Status 144

Male Urinary Catheter With Insertion Tool – Product Description 145

Salusion B.V. Pipeline Products & Ongoing Clinical Trials Overview 146

Home Care Incontinence Device – Product Status 146

Home Care Incontinence Device – Product Description 146

Sharklet Technologies Inc Pipeline Products & Ongoing Clinical Trials Overview 147

Foley Urinary Catheter – Product Status 147

Foley Urinary Catheter – Product Description 147

Stanford University Pipeline Products & Ongoing Clinical Trials Overview 148

OTC Device – Stress Urinary Incontinence – Product Status 148

OTC Device – Stress Urinary Incontinence – Product Description 148

The Feinstein Institute for Medical Research Pipeline Products & Ongoing Clinical Trials Overview 149

Confidence Building Incontinence Pad – Product Status 149

Confidence Building Incontinence Pad – Product Description 149

The University of Nottingham Pipeline Products & Ongoing Clinical Trials Overview 150

Antimicrobial Catheter – Product Status 150

Antimicrobial Catheter – Product Description 150

Tractivus SL Pipeline Products & Ongoing Clinical Trials Overview 151

UroPHOB urinary catheter – Product Status 151

UroPHOB urinary catheter – Product Description 151

University of Amsterdam Pipeline Products & Ongoing Clinical Trials Overview 152

Percutaneous Nephrostomy Catheter – Product Status 152

Percutaneous Nephrostomy Catheter – Product Description 152

University of California San Diego Pipeline Products & Ongoing Clinical Trials Overview 153

Urethral Catheter – Product Status 153

Urethral Catheter – Product Description 153

University of Michigan Pediatric Device Consortium Pipeline Products & Ongoing Clinical Trials Overview 154

M-PED Urinary Incontinence Device – Product Status 154

M-PED Urinary Incontinence Device – Product Description 154

University of North Carolina Pipeline Products & Ongoing Clinical Trials Overview 155

Endoscopic Laser Probe – Stress Urinary Incontinence – Product Status 155

Endoscopic Laser Probe – Stress Urinary Incontinence – Product Description 155

University of Saskatchewan Pipeline Products & Ongoing Clinical Trials Overview 156

Mobile Device – Urinary Incontinence – Product Status 156

Mobile Device – Urinary Incontinence – Product Description 156

University of Sheffield Pipeline Products & Ongoing Clinical Trials Overview 157

Polyurethane Mesh – Product Status 157

Polyurethane Mesh – Product Description 157

University of South Florida Pipeline Products & Ongoing Clinical Trials Overview 158

Bag-less Bladder Drainage Device – Product Status 158

Bag-less Bladder Drainage Device – Product Description 158

Urethral Catheter Guidance System – Product Status 159

Urethral Catheter Guidance System – Product Description 159

University of Texas Health Science Center at San Antonio Pipeline Products & Ongoing Clinical Trials Overview 160

Time Sensitive Foley Catheter Alarm – Product Status 160

Time Sensitive Foley Catheter Alarm – Product Description 160

University of Turin Pipeline Products & Ongoing Clinical Trials Overview 161

Chitosan-Based Incontinence Device – Product Status 161

Chitosan-Based Incontinence Device – Product Description 161

University of Utah Pipeline Products & Ongoing Clinical Trials Overview 162

AdvanceCath Catheter – Product Status 162

AdvanceCath Catheter – Product Description 162

Urinary Assist Device – Product Status 163

Urinary Assist Device – Product Description 163

Urinary BioSolutions LLC (Inactive) Pipeline Products & Ongoing Clinical Trials Overview 164

Urinary Positioning Device – Product Status 164

Urinary Positioning Device – Product Description 164

UroDeflect Pipeline Products & Ongoing Clinical Trials Overview 165

Urinary System Catheter – Product Status 165

Urinary System Catheter – Product Description 165

UroDev Medical Pipeline Products & Ongoing Clinical Trials Overview 166

Connected Catheter System – Product Status 166

Connected Catheter System – Product Description 166

Uromedica Inc Pipeline Products & Ongoing Clinical Trials Overview 167

ACT – Product Status 167

ACT – Product Description 167

Uromedica Inc – Ongoing Clinical Trials Overview 168

ACT – A Clinical Investigation of the Adjustable Continence Therapy (ACT) for Female Stress Urinary Incontinence Due to Intrinsic Sphincter Deficiency 169

ACT – Prospective Study Evaluating the Safety and Effectiveness of Adjustable Continence Therapy (ACT) Balloons for the Management of Urinary Incontinence in Children with Bladder Exstrophy or Incontinent Epispadias 169

UroMems SAS Pipeline Products & Ongoing Clinical Trials Overview 170

UroActive – Product Status 170

UroActive – Product Description 170

UroMems SAS – Ongoing Clinical Trials Overview 171

UroActive – Feasibility Study to Assess the URoMems Artificial Urinary Sphincter in the Treatment of Stress Incontinence in Women 172

Urova Medical Inc. Pipeline Products & Ongoing Clinical Trials Overview 173

UroGuide – Product Status 173

UroGuide – Product Description 173

Urwi Medical Innovations Pvt Ltd Pipeline Products & Ongoing Clinical Trials Overview 174

Second Generation Urinary Incontinence Trainer – Product Status 174

Second Generation Urinary Incontinence Trainer – Product Description 174

Vesiflo, Inc. Pipeline Products & Ongoing Clinical Trials Overview 175

Advanced Bladder Drainage Device – Product Status 175

Advanced Bladder Drainage Device – Product Description 175

Viveve Medical Inc Pipeline Products & Ongoing Clinical Trials Overview 176

Viveve System – Stress Urinary Incontinence – Product Status 176

Viveve System – Stress Urinary Incontinence – Product Description 176

Vysera Biomedical Ltd Pipeline Products & Ongoing Clinical Trials Overview 177

Urinary Incontinence Device – Product Status 177

Urinary Incontinence Device – Product Description 177

Washington University in St Louis Pipeline Products & Ongoing Clinical Trials Overview 178

Wireless Optoelectronic System – Bladder Function – Product Status 178

Wireless Optoelectronic System – Bladder Function – Product Description 178

Watkins Conti Products Inc Pipeline Products & Ongoing Clinical Trials Overview 179

Yoni.Fit – Product Status 179

Yoni.Fit – Product Description 179

Xennovate Medical LLC Pipeline Products & Ongoing Clinical Trials Overview 180

Vortex ZDS Urinary Retention Catheter – Product Status 180

Vortex ZDS Urinary Retention Catheter – Product Description 180

Glossary 246

Incontinence Devices – Pipeline Products by Stage of Development 20

Incontinence Devices – Pipeline Products by Segment 21

Incontinence Devices – Pipeline Products by Territory 22

Incontinence Devices – Pipeline Products by Regulatory Path 23

Incontinence Devices – Pipeline Products by Estimated Approval Date 24

Incontinence Devices – Ongoing Clinical Trials 25